Exchange: NASDAQ·Updated 03:03 PM EDT
AVBP logo

AVBP ArriVent BioPharma Inc.

$31.02
$0.01
(0.03%)
Today
Reported EarningsAug 12
Mkt Cap$1.53B
Vol81,085.00

About AVBP

Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
52

Neutral Sentiment

How do you feel about AVBP?

Advertisement|Remove ads.